Australia Markets closed

Hercules Capital, Inc. (HTGC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
12.80-0.31 (-2.36%)
At close: 04:00PM EDT
12.80 0.00 (0.00%)
After hours: 07:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close13.11
Bid12.65 x 1300
Ask13.04 x 1200
Day's range12.65 - 13.02
52-week range12.62 - 19.09
Avg. volume945,007
Market cap1.484B
Beta (5Y monthly)1.31
PE ratio (TTM)4.57
EPS (TTM)2.80
Earnings date27 Apr 2022 - 02 May 2022
Forward dividend & yield1.40 (8.80%)
Ex-dividend date08 Aug 2022
1y target est17.39
  • Business Wire

    Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.

    PALO ALTO, Calif., September 13, 2022--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. ("KBRA") has reaffirmed Hercules’ investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the reaffirm

  • Zacks

    Implied Volatility Surging for Hercules (HTGC) Stock Options

    Investors need to pay close attention to Hercules (HTGC) stock based on the movements in the options market lately.

  • PR Newswire

    Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital

    Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company has secured a term loan facility of up to $125 million with Hercules Capital, Inc. (NYSE: HTGC), a leader in customized financing for companies in life sciences.